US Earnings Financial Results SEC Filings — September 25, 2026

25-09-2026

Slam Corp. (SLAMF) filed its Form 10-Q for the quarterly period ended June 30, 2025, reporting a net income of $2.9M for Q2 2025, a significant turnaround from a net loss of $1.6M in Q2 2024. The improvement was primarily driven by a $2.9M gain from the change in fair value of derivative warrant liabilities. However, the company continues to report an accumulated deficit of $41.3M and total liabilities of $64.0M, with cash held in trust of $23.8M.

• · Total liabilities increased 48.9% from $42.97M at Dec 31, 2024 to $64.0M at June 30, 2025, driven largely by a $22.5M due to redeeming shareholders.
• · Cash held in Trust Account increased 4.1% from $22.85M to $23.79M.
• · Derivative warrant liabilities decreased 79.0% from $3.11M to $0.65M.
• · Promissory notes—related party increased 10.4% from $12.72M to $14.04M.
• · Net cash used in operating activities increased 55.2% from $0.76M to $1.18M for H1 2025 vs H1 2024.
• · The company had a working capital deficit of $3.24M as of June 30, 2025 (current liabilities of $3.42M exceeded current assets of $0.19M).

25-09-2026

Niocorp Developments Ltd filed its 10-K annual report for the fiscal year ended June 30, 2026, highlighting a significant increase in net loss to $48.6M from $17.4M in FY2025, driven by a tripling of operating expenses to $38.3M. The company reported a strong cash position of $415.0M, up from $25.6M, and disclosed updated project economics for its Elk Creek critical minerals project, including an after-tax NPV8% of $3.4B and an after-tax IRR of 22.8%. However, the net loss per share widened to $(0.41) from $(0.36), and total shareholders' equity surged to $431.2M from $28.3M, reflecting substantial equity financing during the year.

• · The company had 145,838,380 common shares outstanding as of June 30, 2026, up from 58,491,196 a year earlier.
• · Weighted average shares outstanding increased to 117,214,449 in FY2026 from 45,072,895 in FY2025.
• · Accumulated deficit grew to $227.9M as of June 30, 2026 from $179.3M as of June 30, 2025.
• · Total liabilities increased to $37.1M from $14.7M year-over-year.
• · The Elk Creek project has a life of mine of 40 years with a development timeline of 35 months.
• · Revenue per ton for the Elk Creek project is estimated at $815/ton, with an average annual operating cost of $(255)/ton.
• · The Elk Creek project's LoM gross revenue is projected at $37.4B, with scandium contributing the largest share at $14.3B.
• · Change in fair value of earnout shares liability was $8.6M in FY2026 vs $2.1M in FY2025.
• · Change in fair value of warrant liabilities was $13.0M in FY2026 vs $4.1M in FY2025.
• · Interest income increased to $9.1M in FY2026 from $0.1M in FY2025.

25-09-2026

SR Bancorp, Inc. filed its 10-K annual report for the fiscal year ended June 30, 2026, showing a 5.6% increase in net interest income to $31.2M, driven by loan growth and improved net interest margin (3.04% vs 2.93%). However, total noninterest income declined 40.7% to $2.2M, primarily due to the absence of a prior-year $1.5M life insurance gain, while noninterest expense rose 5.2% to $28.5M, led by higher salaries and benefits. The company operates 12 branch offices across New Jersey, with a net book value of $2.5M in owned properties and $0.011M in leasehold improvements.

• · Average loans outstanding increased 9.1% to $841.9M from $771.7M, while average securities decreased 8.1% to $139.3M.
• · Average interest-bearing deposits grew 6.1% to $766.7M, with interest-bearing demand accounts up 20.4% to $355.8M.
• · Average FHLB advances nearly doubled to $44.9M from $24.2M, with cost declining to 3.81% from 4.88%.
• · Noninterest-bearing deposits remained relatively flat at $107.0M vs $105.0M.
• · Equity increased modestly to $193.0M from $191.7M.
• · The company owns 7 branches and leases 5 branches, with total owned property net book value of $2.5M.
• · Leased branches have minimal net book value ($11K for Livingston, $0 for others).

25-09-2026

Woodbridge Liquidation Trust filed its 10-K annual report for the fiscal year ended June 30, 2026, reporting total net assets in liquidation of $35.86M, down from $37.33M in the prior year. The trust's cash and short-term investments decreased to $56.01M from $60.23M, while accrued liquidation costs fell to $23.17M from $26.14M. The trust recorded a net change in carrying value of assets and liabilities of $1.53M for the year, driven by $5.17M in other gains partially offset by a $7.14M remeasurement loss.

• · The trust's Plan Effective Date was June 30, 2026.
• · Restricted cash increased to $0.70M from $0.64M, a 9% YoY increase.
• · Distributions payable increased to $0.70M from $0.64M.
• · Accounts payable and accrued liabilities remained essentially flat at $0.04M.
• · The trust recorded $3.44M in net settlement recoveries for the year.
• · Sales proceeds in excess of carrying value were $0.06M.
• · Other gains totaled $5.17M.
• · The remeasurement of assets and liabilities resulted in a net loss of $7.14M.
• · Net real estate assets held for sale were $582.71M as of the Plan Effective Date, but $0.24M as of June 30, 2026, indicating substantial asset sales.

25-09-2026

Scholastic Corp reported a net loss of $71.2M for the first quarter of fiscal 2027 (three months ended August 31, 2026), essentially flat compared to a $71.1M loss in the prior-year period. Total revenues declined 3.9% to $216.8M from $225.6M, driven by a 24.2% drop in Education segment revenue ($30.4M vs $40.1M) and a 46.3% decline in Trade-International revenue ($6.6M vs $12.3M). However, the Entertainment segment showed strong growth of 47.8% to $20.1M, and the company increased long-term debt by $100M to $175M while repurchasing $25.3M of common stock.

• · Operating income (loss) was -$92.2M in both Q1 FY27 and Q1 FY26, unchanged year-over-year.
• · Cash used in operating activities increased to -$94.6M from -$81.8M, a 15.6% worsening in cash burn.
• · The company borrowed $104.3M under lines of credit and long-term debt in Q1 FY27, up from $78.0M in the prior year.
• · Dividends paid decreased to $3.8M from $5.2M year-over-year, a 26.9% decline.
• · Total assets decreased to $1,725.3M from $1,954.6M year-over-year, a decline of 11.7%.
• · The Overhead segment revenue dropped to $0 from $3.1M year-over-year, a 100% decline.
• · Entertainment - International revenue surged 133.3% to $17.8M from $12.2M.
• · Trade - International revenue fell 46.3% to $6.6M from $12.3M.
• · Book Clubs - U.S. revenue grew 16.7% to $2.1M from $1.8M, though it remains a very small segment.
• · Inventories, net increased to $315.3M from $265.0M at May 31, 2026, a 19.0% increase, while accounts receivable decreased to $186.6M from $236.4M.

25-09-2026

Integrated BioPharma Inc. reported a sharp deterioration in FY2026 results, with net sales falling 19.3% to $43,872 thousand from $54,353 thousand in FY2025, and a swing to a net loss of $2,842 thousand from net income of $808 thousand. The decline was driven by a 18.0% drop in contract manufacturing sales and a 44.4% plunge in other nutraceuticals sales, while gross margin collapsed to 1.8% from 10.2%. Operating cash flow also weakened to $1,241 thousand from $2,065 thousand, though the company ended the year with higher cash of $4,471 thousand.

• · Cost of sales increased to 98.2% of sales in FY2026 from 89.8% in FY2025, driving gross margin down to 1.8%.
• · Selling and administrative expenses rose to 8.0% of sales from 6.5%.
• · Income tax expense fell to $279 thousand from $1,254 thousand.
• · Basic and diluted loss per share were $(0.09) in FY2026 versus earnings per share of $0.03 in FY2025.
• · Net cash used in investing activities increased to $340 thousand from $205 thousand.
• · Net cash used in financing activities was $45 thousand in FY2026 versus $78 thousand provided in FY2025.
• · The company's auditor is CBIZ CPAs P.C. (PCAOB ID 199).

25-09-2026

GenFlat Holdings, Inc. filed its annual report (10-K) for the fiscal year ended September 25, 2026. The company operates in intermodal transportation equipment leasing and container sales, but remains an early-stage company with no disclosed revenue or financial results in this filing. The filing extensively outlines risk factors including inability to generate revenue, lack of funding, cybersecurity threats, and stock price volatility, highlighting the speculative nature of the investment.

• · The company's business consists of equipment leasing (intermodal containers) and contract-manufactured container sales.
• · GenFlat relies on third parties for manufacturing, marketing, sales leads, customer support, and infrastructure.
• · The filing warns of risks from cybersecurity incidents including ransomware, data theft, and social engineering.
• · No active trading market for the company's common stock has developed, and the stock price may be highly volatile.
• · The company faces typical early-stage risks such as inability to manage growth, lack of market acceptance, and competition.

25-09-2026

Tamboran Resources Corp reported a net loss of $30.5M for FY2026, a 23% improvement from a $39.6M net loss in FY2025, driven by lower exploration and LNG feasibility expenses. However, operating cash flow worsened to a $34.6M outflow, and total assets more than doubled to $1.15B, largely due to a $517.9M common stock issuance and the Falcon Acquisition. The company remains pre-revenue with no operating income, and total comprehensive loss attributable to stockholders narrowed to $17.4M from $33.6M.

• · Exploration expense decreased 19% to $3.3M from $4.1M
• · LNG feasibility study expense dropped 98% to $0.1M from $6.0M
• · Checkerboard fee of $5.95M was incurred in FY2025 but not in FY2026
• · Accrued capital expenditure surged to $41.2M from $8.0M
• · Long-term debt increased to $59.0M from $0
• · Total stockholders' equity rose to $796.2M from $287.7M
• · Net loss attributable to noncontrolling interest was $4.4M in FY2026 vs $2.7M in FY2025

25-09-2026

Ferrellgas Partners Finance Corp. reported a significant turnaround for the fiscal year ended July 31, 2026, with net earnings attributable to the partnership of $71.7M compared to a net loss of $15.6M in the prior year. Total revenues declined 3.8% to $1.86B from $1.94B, driven by lower cost of sales, while operating income more than doubled to $198.3M from $90.1M. However, operating expenses increased 3.2% to $651.3M, and interest expense rose 15.6% to $124.9M, partially offsetting the gains.

• · General and administrative expense decreased sharply from $178.6M in FY 2025 to $44.4M in FY 2026, a 75.1% decline.
• · Loss on extinguishment of debt was $3.0M in FY 2026, compared to $0 in FY 2025.
• · Non-cash employee stock ownership plan compensation expense increased 23.5% to $3.9M from $3.1M.
• · Operating expense - equipment lease expense decreased 24.1% to $14.2M from $18.7M.
• · Loss on asset sales and disposals increased 61.5% to $4.8M from $3.0M.
• · Income tax expense decreased 33.7% to $0.9M from $1.4M.
• · The increase in operating expenses was driven by $14.8M in plant and other costs and $7.6M in vehicle expense, partially offset by a $2.0M decrease in personnel expense.
• · The increase in interest expense was primarily due to a $19.2M increase on unsecured notes related to the October 2025 refinancing, partially offset by a $5.4M decrease in amortization costs related to the credit facility.
• · The increase in depreciation and amortization expense was due to $6.5M in amortization expense (primarily finance leases) and $2.2M in depreciation expense.

25-09-2026

CID Holdco, Inc. (DAICW) reported a net loss of $3.77M for Q2 2026, significantly improved from a $28.86M loss in Q2 2025, driven by the absence of large non-cash charges like SAFE note fair value changes. However, revenue collapsed 90% YoY to $12.4K in Q2 2026 from $126.8K in Q2 2025, and operating expenses surged 31% to $3.04M, with general and administrative costs more than doubling. The company ended the period with only $456K in cash, down 93% from $6.49M a year earlier, and shareholders' equity turned negative to -$6.05M.

• · A 1-for-25 reverse stock split was effective May 29, 2026, and all share/per-share data are adjusted for it.
• · At the ShoulderUp closing, 506,589 pre-split shares were issued to public shareholders (20,264 post-split); 6,698,333 pre-split shares were issued to officers, directors, sponsor, and transferees (267,933 post-split).
• · Net cash used in operating activities was $1.71M in H1 2026 vs. $6.39M in H1 2025.
• · Cash paid for interest in H1 2026 was $778,691 vs. $0 in H1 2025.
• · Conversion of third-party short-term debt to equity was $895,155 in H1 2026 vs. $2.46M in H1 2025.
• · No provision for income taxes was recorded in any period.

25-09-2026

Lakeside Holding Ltd reported a significant increase in revenue for FY2026, reaching $5,850,681, up 111.8% from $2,762,465 in FY2025, driven by growth in continuing operations. However, the company's net loss from continuing operations widened substantially to $(10,138,418) from $(1,898,782) in the prior year, impacted by a $2.56M gain on the sale of ABL Chicago offset by higher operating expenses and write-offs. Discontinued operations also swung to a net loss of $(3,347,354) from a loss of $(654,388) in the prior year, reflecting a 119.5% decline.

• · Cash used in operating activities from continuing operations worsened to $(3,183,694) in FY2026 from $(778,830) in FY2025.
• · Cash used in investing activities from continuing operations increased to $(9,152,409) from $(330,793) YoY.
• · Net cash provided by financing activities from continuing operations decreased to $7,767,642 from $8,581,938.
• · Current assets rose to $11,019,992 as of June 30, 2026, from $10,278,926 a year earlier.
• · Current liabilities fell sharply to $4,486,989 as of June 30, 2026, from $9,666,053 as of June 30, 2025.
• · Write-off of supplier advance was $2,859,594 in FY2026.
• · Provision for expected credit loss on loan receivable was $2,256,647 in FY2026.

25-09-2026

Propanc Biopharma, Inc. filed its 10-K annual report for the fiscal year ended June 30, 2026, reporting no revenue and a net loss of $18.86 million, a significant improvement from the $58.92 million net loss in FY2025. The company strengthened its cash position to $832,006 from just $12,088 a year earlier, driven by $6.46 million in financing activities including Series C preferred stock and warrant exercises. However, operating expenses remained high at $18.19 million, and the accumulated deficit grew to $144.48 million, with no revenue generated in either period.

• · Revenue remained zero for both FY2026 and FY2025.
• · Net loss per share improved from ($371.22) in FY2025 to ($17.62) in FY2026.
• · Research and development expenses increased 179.6% from $223,721 in FY2025 to $625,477 in FY2026.
• · Professional and consulting expenses decreased 56.7% from $33,622,510 in FY2025 to $14,572,616 in FY2026.
• · Compensation and related taxes decreased 90.2% from $23,296,390 in FY2025 to $2,275,937 in FY2026.
• · The company has a royalty agreement with the University of Bath, paying 2% of all net revenues.
• · Total comprehensive loss improved from ($58,873,964) in FY2025 to ($19,937,618) in FY2026.
• · Interest expense decreased 23.6% from $563,757 in FY2025 to $430,539 in FY2026.
• · The company issued 1,368,451 shares of common stock upon conversion of Series C preferred stock.
• · Proceeds from the sale of common stock were $3,314,458 in FY2026 versus $0 in FY2025.
• · Proceeds from exercise of Series C warrants were $3,000,000 in FY2026 versus $0 in FY2025.
• · Deemed dividend of $932,246 was recorded related to Series C Preferred Stock in FY2026.
• · Prepaid expenses (current portion) decreased 8.1% from $8,334,046 at June 30, 2025 to $7,661,967 at June 30, 2026.
• · Prepaid expenses (long-term portion) decreased 61.6% from $10,925,835 at June 30, 2025 to $4,190,543 at June 30, 2026.
• · Accounts payable decreased 9.5% from $1,249,596 at June 30, 2025 to $1,131,429 at June 30, 2026.
• · Accrued expenses and other payables decreased 42.5% from $1,486,550 at June 30, 2025 to $855,350 at June 30, 2026.
• · Employee benefit liability increased 12.9% from $667,901 at June 30, 2025 to $754,038 at June 30, 2026.
• · The company had no convertible notes or embedded conversion option liabilities at June 30, 2026, compared to $537,921 and $403,892 respectively at June 30, 2025.
• · Property and equipment, net increased from $0 at June 30, 2025 to $3,915 at June 30, 2026.
• · Operating lease right-of-use assets decreased 31.3% from $59,413 at June 30, 2025 to $40,790 at June 30, 2026.
• · Accumulated other comprehensive income decreased 10.8% from $1,318,917 at June 30, 2025 to $1,176,255 at June 30, 2026.
• · Treasury stock remained unchanged at ($46,477) in both periods.

25-09-2026

SunHydrogen, Inc. reported a net loss of $6.53M for FY2026, an improvement from the $8.23M loss in FY2025, driven by higher investment income and the absence of a prior-year unrealized loss on a related-party investment. However, operating expenses rose 29% to $7.52M, and cash and cash equivalents fell sharply by 65% to $12.13M from $34.63M, reflecting heavy investment in short-term securities and a $1.0M preferred stock repurchase. The company generated only $1,250 in revenue, underscoring its pre-commercial stage.

• · Revenue was minimal at $1,250 for FY2026, compared to $0 in FY2025.
• · Research and development expenses increased 26% YoY to $4.33M from $3.44M.
• · General and administrative expenses increased 31% YoY to $3.05M from $2.34M.
• · Investment income decreased 29% YoY to $1.24M from $1.74M.
• · The company recorded a deemed dividend of $851,400 on repurchase of preferred stock in FY2026.
• · Cash used in operating activities increased 39% YoY to $5.07M from $3.65M.
• · Net cash used in investing activities increased to $17.20M from $2.92M, primarily due to purchases of short-term investments.
• · Financing activities provided $2.16M in FY2025 but used $0.23M in FY2026.
• · Weighted-average basic and diluted shares outstanding increased to 5.53 billion from 5.32 billion.
• · The company had a foreign currency translation adjustment loss of $11,992 in FY2026.
• · Operating lease right-of-use asset of $102,014 and corresponding liabilities were recognized in FY2026.

25-09-2026

Amplify Commodity Trust (BWET) filed its 10-K annual report for the fiscal year ended June 30, 2026, reporting combined net assets of $45,120,211 as of June 30, 2026, down from $67,146,259 as of June 30, 2025, a decline of 32.8%. The Dry Bulk Shipping ETF net assets fell to $29,999,941 from $65,816,264, while the Tanker Shipping ETF net assets dropped sharply to $15,120,270 from $1,329,995, reflecting a significant shift in asset allocation and unrealized losses on futures contracts.

• · Dry Bulk Shipping ETF net asset value per share was $12.12 as of June 30, 2026, with a market value per share of $11.87.
• · Tanker Shipping ETF net asset value per share was $151.05 as of June 30, 2026, with a market value per share of $148.38.
• · Dry Bulk Shipping ETF had 2,475,040 shares outstanding as of June 30, 2026, while Tanker Shipping ETF had 100,100 shares outstanding.
• · Combined segregated cash held by broker was $43,281,306 as of June 30, 2026, compared to $22,114,350 and $949,850 for Dry Bulk and Tanker ETFs respectively in the prior year.
• · Dry Bulk Shipping ETF had net unrealized appreciation of $316,510 on futures contracts as of June 30, 2026, compared to net unrealized depreciation of $861,490 as of June 30, 2025.
• · Tanker Shipping ETF had net unrealized depreciation of $4,753,614 on futures contracts as of June 30, 2026, with the largest losses on Middle East Gulf to China route contracts.
• · Combined total liabilities were $7,574,173 as of June 30, 2026, including $4,753,614 in unrealized depreciation on futures contracts and $2,271,473 payable for fund shares redeemed.

25-09-2026

ASTROTECH Corp (ASTC) filed its 10-K annual report for the fiscal year ended June 30, 2026, reporting a net loss of $14.4 million, widening from a $13.9 million loss in the prior year. Revenue declined 13.0% to $913,000 from $1,049,000, while gross margin collapsed from 45.3% to 23.8%. The company highlighted significant risks related to its development-stage Lunar Initiatives, dependence on government contracts, and the proposed sale of its 1st Detect business.

• · SG&A expenses increased 11.4% to $7,871,000, driven by higher legal costs ($392,000) related to the 2026 offering activities, increased labor and fringe ($230,000) including severance for the former CFO, and higher facilities expense ($181,000).
• · R&D expenses decreased 20.4% to $6,484,000, primarily due to lower consulting expenses ($1.4 million) and lower material/equipment costs ($436,000).
• · Total assets declined 24.0% to $20,507,000 from $26,989,000, driven by a $6,049,000 decrease in current assets.
• · The company's cash burn continues with no indication of near-term profitability, and it faces significant uncertainty around its Lunar Initiatives and the proposed sale of 1st Detect.

25-09-2026

Cracker Barrel's FY2026 10-K shows total revenue declined 4.7% to $3,318.7M from $3,483.7M in FY2025, with both restaurant and retail segments contracting. Comparable store restaurant sales fell 4.2% and retail sales dropped 5.2%, driven by a 7.6% decline in guest traffic, though average check rose 3.7%. The company swung to an operating loss of 0.4% of revenue (vs. 1.6% operating income in 2025) and net income margin fell to 1.0% from 1.3%, reflecting higher labor, store operating, and impairment costs, partially offset by a litigation settlement gain.

• · Breakfast day-part contributed 29% of restaurant sales in 2026, lunch 40%, dinner 31%.
• · Cost of goods sold improved slightly to 30.9% of revenue from 31.0%.
• · Labor and other related expenses rose to 37.3% of revenue from 36.0%.
• · Other store operating expenses increased to 25.5% of revenue from 24.6%.
• · General and administrative expenses increased to 6.4% of revenue from 6.2%.
• · Gain on sale and leaseback transaction net was 1.4% of revenue in 2026 (vs. none in 2025).
• · Impairment and store closing costs rose to 0.9% of revenue from 0.6%.
• · Loss on sale of business assets was 0.8% of revenue in 2026 (vs. none in 2025).
• · Litigation settlement income was 1.4% of revenue in 2026 (vs. none in 2025).
• · Interest expense net declined to 0.4% of revenue from 0.6%.
• · Income tax benefit was 0.4% of revenue in 2026 vs. 0.2% in 2025.
• · Restaurant revenue mix was 81.4% of total revenue in 2026 vs. 81.3% in 2025; retail mix was 18.6% vs. 18.7%.
• · Comparable store sales and traffic exclude MSBC.

25-09-2026

Donaldson Company reported fiscal 2026 net sales of $3,885.6M, up 5.3% from $3,690.9M in fiscal 2025, driven by pricing (+$67.3M), volume (+$29.5M), and acquisitions (+$30.3M). Net earnings rose 23.6% to $453.8M ($3.85 diluted EPS) from $367.0M ($3.05), helped by the absence of a prior-year $62.0M impairment charge. However, Industrial Solutions segment earnings before income taxes fell 21.3% to $155.6M, and On-Road sales declined 6.6% to $103.3M, partially offsetting gains in Mobile Solutions (+5.6%) and Life Sciences (+12.8%).

• · Gross profit margin declined slightly from 34.8% in FY2025 to 34.6% in FY2026.
• · Selling, general and administrative expenses increased 5.8% to $679.2M, representing 17.5% of net sales (vs 17.4% in FY2025).
• · Research and development spending decreased 13.3% to $76.1M (2.0% of net sales vs 2.4% in FY2025).
• · Interest expense rose 48.8% to $36.0M from $24.2M.
• · U.S. and Canada net sales grew only 1.2% to $1,652.0M, while EMEA grew 10.6% to $1,136.0M, APAC grew 8.5% to $689.5M, and LATAM grew 3.1% to $408.1M.
• · Industrial Solutions segment earnings before income taxes margin contracted sharply from 17.9% to 13.7%.
• · Life Sciences segment earnings before income taxes surged to $32.3M from $4.4M, though the prior year was depressed by impairment charges.
• · Corporate and unallocated expenses improved to $69.6M from $127.5M, a reduction of $57.9M.
• · Foreign currency translation had a net positive impact of $67.6M on total net sales and $1.8M on net earnings.
• · Acquisitions contributed $30.3M to net sales growth.

25-09-2026

Marine Petroleum Trust (MARPS) filed its 10-K annual report for the fiscal year ended June 30, 2026. Oil sales volumes increased 10.8% to 14,076 bbls, but the average oil price fell 14.4% to $63.88/bbl. Natural gas volumes declined 16.4% to 16,328 mcf, while natural gas liquids volumes dropped 13.3% to 30,519 mcf. Total assets rose slightly to $950,674 from $921,527, with no debt or current liabilities.

• · The trust has no debt or current liabilities as of June 30, 2026.
• · Federal income taxes payable and refundable were both zero for both fiscal years.
• · Producing oil and gas properties are carried at a nominal value of $7.
• · Trust corpus increased to $950,674 from $921,527, reflecting retained cash.

25-09-2026

Cannabis Suisse Corp. reported a net income of $122,739 for the year ended May 31, 2026, a significant improvement from a net loss of $456,142 in the prior year, driven by a $455,214 non-cash amortization of debt premium and a $551,677 loss on settlement of debt that did not recur. However, the company's gross profit turned negative to ($931) from a positive $432, and total assets declined to $407,479 from $635,075, while cash dropped sharply to $476 from $2,850. The company remains in a stockholders' deficit of $1,679,233, indicating ongoing financial distress.

• · Total liabilities decreased to $2,086,712 from $2,437,047 YoY.
• · Convertible notes payable - related parties decreased to $1,521,313 from $2,111,527.
• · Operating lease liabilities - related parties in default increased to $107,000 from $0.
• · Accrued interest - related parties more than doubled to $122,864 from $58,208.
• · Total lease expense decreased to $220,900 from $240,517.
• · Diluted weighted-average shares outstanding increased to 210,884,922 from 70,680,938 due to convertible notes.
• · Cash paid for interest dropped to $0 from $5,000.
• · Net cash used in operating activities improved to ($40,324) from ($45,112).

25-09-2026

Home Federal Bancorp, Inc. of Louisiana (HFBL) filed its annual 10-K report for the fiscal year ended June 30, 2026, showing strong financial performance. Net income surged 58.8% YoY to $6.174 million, driven by a 16.7% increase in net interest income to $21.789 million and a significant improvement in the average interest rate spread to 3.07%. However, asset quality metrics showed a mixed picture, with non-performing loans as a percentage of net loans rising to 0.64% from 0.51% YoY, and the allowance for credit losses increasing to 1.03% of total loans from 0.96%.

• · Total interest income increased to $32.498M in FY 2026 from $30.462M in FY 2025.
• · Total interest expense decreased to $10.709M in FY 2026 from $11.791M in FY 2025.
• · Provision for loan losses was $594,000 in FY 2026, compared to a recovery of $126,000 in FY 2025.
• · Total non-interest income increased to $2.672M in FY 2026 from $2.005M in FY 2025.
• · Total non-interest expense decreased slightly to $16.082M in FY 2026 from $16.148M in FY 2025.
• · Book value per share increased to $19.31 as of June 30, 2026, from $17.90.
• · The efficiency ratio improved significantly to 65.74% in FY 2026 from 78.11% in FY 2025.
• · The dividend payout ratio decreased to 26.94% in FY 2026 from 41.90% in FY 2025.
• · Non-accruing one-to-four family residential loans increased sharply to $2.197M as of June 30, 2026, from $711,000.
• · Accruing loans 90 days or more past due increased to $453,000 from $252,000 YoY.

25-09-2026

Incannex Healthcare Inc. (IXHL) filed its 10-K annual report for the fiscal year ended June 30, 2026, reporting a net loss of $19.3M, a significant improvement from the $46.9M net loss in FY2025. The company had no revenue in FY2026 compared to $86K in the prior year. Operating expenses decreased 4% to $23.0M, driven by a 52% reduction in R&D spending, though G&A expenses increased 36% to $17.8M. Cash and cash equivalents surged to $67.7M from $15.0M, primarily due to $78.7M in share issuance proceeds, partially offset by $9.4M in share repurchases.

• · Net cash used in operating activities was $12.9M in FY2026, nearly flat compared to $12.5M in FY2025.
• · Net cash provided by financing activities was $65.9M in FY2026, up from $21.4M in FY2025.
• · The company had $4.1M in warrant liabilities at June 30, 2026, compared to $0 in the prior year.
• · Accumulated deficit grew to $176.9M at June 30, 2026 from $157.6M a year earlier.
• · Foreign currency translation reserve was negative $3.6M at June 30, 2026, compared to negative $3.1M at June 30, 2025.
• · Total liabilities decreased to $5.6M at June 30, 2026 from $7.1M at June 30, 2025.
• · The company had no revenue in FY2026, compared to $86K in FY2025.
• · R&D tax incentive increased 165% to $4.7M in FY2026 from $1.8M in FY2025.
• · Stock-based compensation expense increased 190% to $7.6M in FY2026 from $2.6M in FY2025.
• · The company repurchased 2,205,653 shares for $9.4M in FY2026.